Company: TEM
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000950170-25-025603
Chunk: 64

Company: Tempus AI, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 1
Chunk 64
---
 to incur losses in the future, and we may not be able to generate sufficient revenue to achieve and maintain profitability. 

•Our current or future products may not achieve or maintain sufficient commercial market acceptance. 

•Our operating results may fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide. 

•The success of our business depends on our continued access to, and ability to monetize, de-identified patient data. 

•Our limited operating history and rapid growth make it difficult to evaluate our future prospects and the risks and challenges we may encounter. 

51

•We may need to raise additional capital to fund our existing operations, develop our Platform, commercialize new products or expand our operations. 

•Our AI Applications product line is nascent. 

•Our diagnostic products, or our competitors’ diagnostic products, could have defects or errors or otherwise fail to meet the expectations of patients, physicians and third-party payers; in such cases our operating results, reputation and business could suffer. 

•If third-party payers, including commercial payers and government healthcare programs, do not provide coverage of, or adequate reimbursement for, or reverse or change their policies related to our tests, our business, financial condition and results of operations will be negatively affected. 

•If we are unable to obtain or maintain adequate reimbursement for our Genomics product line outside of the United States, our ability to expand internationally will be compromised. 

•Labor relations matters could have a material adverse effect on our business, reputation, prospects, results of operations and financial condition. 

•We use AI in our products and services which may result in operational challenges, legal liability, reputational concerns and competitive risks. 

•If we cannot compete successfully with our competitors, we may be unable to increase or sustain our revenue or to achieve and then sustain profitability. 

•The industries in which we operate are subject to rapid change, which could make our Platform, our current products and any future products we may develop obsolete. 

•Our existing and any future debt may affect our flexibility in operating and developing our business and our ability to satisfy our obligations. 

•We rely on a limited number of suppliers or, in some cases, sole suppliers, for some of our laboratory instruments and materials and may not be able to find replacements or promptly transition to alternative suppliers. 

•International expansion of our business exposes us to business, regulatory, political, operational, financial, and economic risks associated with doing business